A recent study has shown that the prevalence of glomerular damage in adults with various forms of sickle cell anemia is much higher than previously thought. Guasch and colleagues investigated the ...

Obesity, uncontrolled diabetes and hypertension are the main risk factors for the development of kidney diseases. In this ...

When you have complement 3 (C3) glomerulopathy, a problem with your immune system can damage your kidneys. You’ll take medicine to control your immune system and protect your kidneys.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

CFI deficiency can also manifest in renal conditions such as atypical hemolytic uremic syndrome, complement 3 glomerulopathy, or immune-complex membranoproliferative glomerulonephritis.

Zaltenibart is under clinical development by Omeros and currently in Phase I for Kidney Disease (Nephropathy).

Zaltenibart is under clinical development by Omeros and currently in Phase II for Paroxysmal Nocturnal Hemoglobinuria.

Also known as membranous glomerulopathy – MN is one of the many glomerular diseases causing nephrotic syndrome, characterized by massive proteinuria and clinically presents with peripheral edema ...

Meanwhile, ADX-097 provides localized inhibition of the complement system to manage immune-mediated kidney diseases, including lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA ...

include paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uraemic syndrome (aHUS), C3 glomerulopathy (C3G), and idiopathic membranous nephropathy (IMN).